Sub-group of PIK3CA WT breast cancer patients have hyperactive S1P signaling tumor cells responsive to PIK3-inhibitors: Functional signaling profile test identifies new patient group who may benefit from PIK3-targeted therapies-MedSci.cn

Sub-group of PIK3CA WT breast cancer patients have hyperactive S1P signaling tumor cells responsive to PIK3-inhibitors: Functional signaling profile test identifies new patient group who may benefit from PIK3-targeted therapies

Laing, L; Khan, S; MacNeil, I; Kuzmicki, C; Kharbush, S; Rich, B; Shukla, AS; Brass, KB; Sullivan, BS

CANCER RESEARCH, 2020; 80 (4):

科室
- - 订阅+
  - 更多科室
工具
服务